The cannabinoid dehydroxylcannabidiol suppresses neuropathic pain by upregulating a spinal glycine receptor-mediated compensation mechanism
Abstract Neuropathic pain (NP) is well-known to be complicated and challenging to manage. Organisms have been shown to initiate various…